Inovio Pharmaceuticals Inc

Type: Company
Name: Inovio Pharmaceuticals Inc
First reported Apr 15 2014 - Updated Apr 15 2014 - 1 reports

Inovio Pharmaceuticals CEO Jong Joseph Kim Purchases 25,000 Shares (INO)

Inovio Pharmaceuticals (NYSE:INO) CEO Jong Joseph Kim bought 25,000 shares of the company’s stock in a transaction dated Tuesday, April 15th. The shares were purchased at an average price of $2.25 per share, for a total transaction of $56,250.00. Following ... [Published American Banking News - Forex - Apr 15 2014]
First reported Apr 10 2014 - Updated Apr 10 2014 - 1 reports

Inovio Pharmaceuticals Continues Building Its Senior Team With the Appointment of VP of Quality

By a News Reporter-Staff News Editor at Biotech Week -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced the appointment of E.J. Brandreth as Vice President of Quality. He will be responsible for all quality and compliance functions for a company ... [Published HispanicBusiness.com - Apr 10 2014]
First reported Apr 09 2014 - Updated Apr 09 2014 - 1 reports

Short Interest in Inovio Pharmaceuticals Grows By 16.6% (INO)

Inovio Pharmaceuticals (NYSE:INO) was the recipient of a large growth in short interest in January. As of March 31st, there was short interest totalling 28,233,502 shares, a growth of 16.6% from the March 14th total of 24,207,003 shares, AnalystRatingsNetwork.com ... [Published American Banking News - Apr 09 2014]
First reported Apr 05 2014 - Updated Apr 05 2014 - 1 reports

Recently released market study: Inovio Pharmaceuticals, Inc. (INO) - Financial and Strategic SWOT Analysis Review

(live-PR.com) - Inovio Pharmaceuticals, Inc. (INO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you ... [Published Live-PR.com - Apr 05 2014]
First reported Apr 04 2014 - Updated Apr 04 2014 - 2 reports

ProActive Capital Group's Rebuttal To Richard Pearson

In a blog by Richard Pearson that was published on Seeking Alpha last week there were numerous accusations about ProActive Capital Group (PCG) that were grossly inaccurate, misleading and irresponsible. Seeking Alpha has updated the article clarifying ... [Published BioPortfolio - Apr 04 2014]
First reported Apr 01 2014 - Updated Apr 01 2014 - 6 reports

Inovio Appoints Quality VP

E.J. Brandreth has been appointed vice president of Quality at Inovio Pharmaceuticals, Inc. Mr. Brandreth will be responsible for all quality and compliance functions for clinical trials and scaling up manufacturing and other operations to support the ... [Published Contract Pharma - Apr 01 2014]
First reported Mar 31 2014 - Updated Mar 31 2014 - 2 reports

Neutral Trend For Red Hat Inc. (NYSE:RHT)

The overall weekly trend for the stock seems to be neutral. There was a selling pressure last week. However, the stock is currently at an important support area. So it is important to see if there is follow up selling this week. Important support exists ... [Published Live Trading News - Mar 31 2014]
First reported Mar 26 2014 - Updated Mar 26 2014 - 4 reports

Inovio Pharmaceuticals Recognized with Best Therapeutic Vaccine Award at World Vaccine Congress 2014

Biotech Judged First-in-Class for Cervical Pre- Cancer Immunotherapy (VGX-3100), Which Reports Phase II Results Mid-year 2014 Also Awarded “Best Vaccine Licensing Deal” and “Best Early Stage Biotech” March 26, 2014 Inovio Pharmaceuticals, Inc. today ... [Published BioPortfolio - Mar 26 2014]
First reported Mar 26 2014 - Updated Mar 26 2014 - 2 reports

3 Biotechs Expecting Top Line Phase 2 Data Mid 2014

By Kyle's Picks :When it comes to small/mid size biotech companies, it's no secret clinical data is king, often pushing the stock prices to new highs upon positive results. Biota Pharmaceuticals ( BOTA ), Inovio Pharmaceuticals ( INO ) and Athersys ( ... [Published BioPortfolio - Mar 26 2014]
First reported Mar 25 2014 - Updated Mar 25 2014 - 1 reports

Inovio Pharmaceuticals Sees Large Growth in Short Interest (INO)

Inovio Pharmaceuticals (NYSE:INO) saw a large growth in short interest in January. As of March 14th, there was short interest totalling 24,207,003 shares, a growth of 6.3% from the February 28th total of 22,762,993 shares, StockRatingsNetwork reports. ... [Published American Banking News - Mar 25 2014]
First reported Mar 20 2014 - Updated Mar 20 2014 - 1 reports

Inovio Pharmaceuticals Stock Rating Upgraded by Zacks (INO)

Other equities research analysts have also recently issued reports about the stock. Analysts at Maxim Group raised their price target on shares of Inovio Pharmaceuticals from $3.00 to $6.00 in a research note on Tuesday. They now have a “buy” rating on ... [Published American Banking News - Forex - Mar 20 2014]
First reported Mar 18 2014 - Updated Mar 18 2014 - 1 reports

Inovio Pharmaceuticals Given New $6.00 Price Target at Maxim Group (INO)

Stock analysts at Maxim Group upped their price target on shares of Inovio Pharmaceuticals (NYSE:INO)Other equities research analysts have also recently issued reports about the stock. Analysts at Piper Jaffray raised their price target on shares of Inovio ... [Published American Banking News - Mar 18 2014]

Quotes

Boston, MA -- (SBWIRE) -- 04/16/2014 -- Global Markets Direct's, "Rheumatoid ', provides an overview of the Rheumatoid Arthritis's therapeutic pipeline."
"Specifically, we will rely on E J Brandreth's track record of moving pipeline candidates such as Rituxan(R) and Zevalin(R) to commercialization as we ramp up our immunotherapies and DNA vaccines into later stage clinical trials. We are also pleased to promote from within our executives who have demonstrated outstanding results."
...on both Inovio Pharmaceuticals (INO) and Unilife Corp (UNIS), using IR (investment relations) firm the Proactive Group,'' reads the story. "In both cases, the promotions took place in conjunction with the release of news and boosted the stock. All the stocks mentioned so far have several things in common: They have minimal investment from institutions and are overwhelmingly held by retail investors who can be easily influenced by paid promotions."

More Content

All (117) | News (98) | Reports (0) | Blogs (9) | Audio/Video (0) | Fact Sheets (0) | Press Releases (9)
sort by: Date | Relevance
Rheumatoid Arthritis - Pipeline Review, H1 2014... [Published Digital Journal - Apr 16 2014]
Inovio Pharmaceuticals CEO Jong Joseph Kim Purc... [Published American Banking News - Forex - Apr 15 2014]
Recently Released Market Study: Hepatitis C - P... [Published SBWire - Apr 11 2014]
Inovio Pharmaceuticals Continues Building Its S... [Published HispanicBusiness.com - Apr 10 2014]
Short Interest in Inovio Pharmaceuticals Grows ... [Published American Banking News - Apr 09 2014]
Wednesday's ETF Movers: XBI, GDXJ [Published Nasdaq - Apr 09 2014]
I Hear The Shorts Knocking, But, I'm Staying Lo... [Published Seeking Alpha - Apr 09 2014]
Active Stocks Coverage -- Research on Mallinckr... [Published TickerTech.com - Apr 08 2014]
Active Stocks Coverage -- Research on Mallinckr... [Published Financial Services - Apr 08 2014]
Why I’m Bullish on 3D Systems (DDD) Despite Pri... [Published I Stock Analyst - Apr 07 2014]
5 Biotechs With Prostate Cancer Treatments Wort... [Published Motley Fool Discussion Boards - Apr 05 2014]
Recently released market study: Inovio Pharmace... [Published Live-PR.com - Apr 05 2014]
ProActive Capital Group's Rebuttal To Richard P... [Published BioPortfolio - Apr 04 2014]
ProActive Capital Group's Rebuttal To Richard P... [Published Seeking Alpha - Apr 04 2014]
Novartis gets new head of Japanese business ami... [Published FierceBiotech - Apr 04 2014]
Why I'm bullish on 3D Systems despite pricey va... [Published FOXBusiness.com - Apr 03 2014]
Neutral Trend For BlackBerry Ltd (NASDAQ:BBRY) [Published Live Trading News - Apr 01 2014]
HEFFX Gold Report [Published Live Trading News - Apr 01 2014]
Inovio Appoints Quality VP [Published Contract Pharma - Apr 01 2014]
Inovio Pharmaceuticals appoints EJ Brandreth as... [Published Pharma Letter - Apr 01 2014]
Inovio Pharmaceuticals Inc. (NYSEMKT:INO) Gets ... [Published Live Trading News - Apr 01 2014]
Inovio Pharmaceuticals Continues Building Its S... [Published TheStreet.com - Apr 01 2014]
Inovio Pharmaceuticals Continues Building Its S... [Published PR Newswire - Apr 01 2014]
Inovio Pharmaceuticals Continues Building Its S... [Published Scottrade - Apr 01 2014]
HIV Vaccine Market Opportunity & Clinical Pipel... [Published TickerTech.com - Apr 01 2014]
Patent Wars: Apple Inc (NASDAQ:AAPL) Again Take... [Published Live Trading News - Mar 31 2014]
Neutral Trend For Red Hat Inc. (NYSE:RHT) [Published Live Trading News - Mar 31 2014]
Inovio Pharmaceuticals Inc. (NYSEMKT:INO) To Co... [Published Live Trading News - Mar 31 2014]
Neutral Trend For MannKind Corporation (NASDAQ:... [Published Live Trading News - Mar 31 2014]
Voelte sidesteps Nexus conflict [Published Brisbane Times - Mar 31 2014]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Inovio Pharmaceuticals to Report Fourth Quarter... [Published PR Newswire: Health - Mar 12 2014]
BLUE BELL, Pa., March 12, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it will host a conference call and live webcast to report its fourth quarter and year end 2013 financial results on Monday, March 17, ...
BioNews – 03/04/14 [Published eClinical Trends - Mar 04 2014]
Top News HeadlineCompanyType U.K. begins trying to rebuild trust in patient database after months of 'confusion, suspicion and anxiety' NHSEHR FDA defends itself against accusations its email snooping broke whistleblower laws FDASecurity Google joins ...
Inovio Pharmaceuticals Announces Pricing of Pub... [Published PR Newswire: Health - Feb 27 2014]
BLUE BELL, Pa., Feb. 27, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) ("Inovio" or the "Company"), today announced the pricing of an underwritten public offering of 18,966,000 shares of common stock for a public offering price ...
U.S. Stock Futures Little Changed on Data Befor... [Published Bloomberg via Google News - Feb 27 2014]
U.S. Stock Futures Little Changed on Data Before Yellen Bloomberg A Commerce Department release at the same time will show that durable-goods orders fell 1.7 percent in January, according to the median estimate in a Bloomberg survey. Inovio Pharmaceuticals ...
Inovio Pharmaceuticals Announces Public Offerin... [Published PR Newswire: Financial Services - Feb 26 2014]
BLUE BELL, Pa., Feb. 26, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) ("Inovio" or the "Company"), today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Piper Jaffray ...
1 2

Press Releases

sort by: Date | Relevance
Active Stocks Coverage -- Research on Mallinckr... [Published Financial Services - Apr 08 2014]
Inovio Pharmaceuticals Reports 2013 Fourth Quar... [Published Financial Services - Mar 17 2014]
Inovio Pharmaceuticals Closes $63.3 Million Und... [Published Financial Services - Mar 04 2014]
Inovio's Revolutionary DNA Immunotherapy Produc... [Published Financial Services - Feb 26 2014]
Market Technicals Simplified: Inovio Pharma, Se... [Published Financial Services - Jan 16 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.